Gastrointestinal stromal tumor (GIST) is the most common malignant neoplasm of
mesenchymal origin. GIST spans a wide clinical spectrum that ranges from tumors with …

Gastrointestinal stromal tumours (GISTs) are soft-tissue sarcomas of the gastrointestinal
tract. Surgery is the standard treatment for localised disease, but the risk of relapse and …

Background The administration of adjuvant imatinib during 3 years is indicated after
resection of primary localized GIST at high risk of recurrence, but many patients relapse …

Simple Summary This review summarises the systemic treatment options available for
patients with gastrointestinal stromal tumours (GIST). While surgical treatment is …

Simple Summary Gastrointestinal stromal tumor (GIST) is the most common type of sarcoma
that arises from the gastrointestinal tract, most frequently from the stomach. The malignancy …

Purpose: Limited data are available about the influence of KIT and PDGFRA mutations on
overall survival (OS) of patients with gastrointestinal stromal tumor (GIST) treated with …

Background: Vitamin D, as a common micronutrient, has been widely used in critically ill
patients. However, whether supplementation of vitamin D in adult patients with sepsis can …

Simple Summary Gastrointestinal stromal tumors (GISTs) are rare malignancies of the
gastrointestinal tract recognized by their clinical presentation and using specific …

Gastrointestinal stromal tumor (GIST) is the most common malignant neoplasm of
mesenchymal origin, and a paradigmatic model for a successful rational development of …

Background: The majority of gastroinstestinal stromal tumours (GISTs) harbour oncogenic
mutations in the gene encoding for the tyrosine kinase (TK) KIT. The most common …